Skip to main content
Clinical Trials/CTRI/2023/09/057283
CTRI/2023/09/057283
Not yet recruiting
Phase 2

A comparative clinical study to evaluate the effect of kayaseka followed by nitya virechana and sadyo virechana in amavata (Rheumatoid arthritis) - Nil

Priyanka Kalal0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Sponsor
Priyanka Kalal
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Priyanka Kalal

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects aged between 18\-60 years of both genders.
  • 2\.Subjects fulfilling the diagnostic criteria of Amavata.
  • 3\.Subjects indicated for Kayaseka and Virechana.

Exclusion Criteria

  • 1\.Subjects associated with uncontrolled Diabetes Mellitus, Hypertension, Cardiac diseases and other systemic disorders.
  • 2\.Rheumatoid arthritis patients with gross deformity.
  • 3\.Pregnant and lactating women.
  • Patient with skin lesions, cuts, wounds

Outcomes

Primary Outcomes

Not specified

Similar Trials